Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2024 | Option Exercise | $47.62 | 1,824 | 86,859 | 56,330 | Apr 03, 2024, 04:01 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Feb 05, 2024 | Sale | $49.32 | 4,834 | 238,435 | 58,154 | Feb 05, 2024, 09:24 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Feb 02, 2024 | Sale | $44.37 | 3,222 | 142,976 | 65,121 | Feb 05, 2024, 09:24 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,507 | 95,166 | 67,659 | Jan 08, 2024, 09:06 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,449 | 60,177 | 66,210 | Jan 08, 2024, 09:06 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $25.25 | 1,375 | 34,719 | 43,721 | Apr 05, 2023, 04:46 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,665 | 45,821 | 45,096 | Jan 09, 2023, 05:00 PM | |
SWTX | SpringWorks Therapeutics, Inc. | Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2022 | Option Exercise | $56.90 | 1,464 | 83,302 | 24,098 | Oct 13, 2022, 04:03 PM |